Back to Search
DAVID MORRIS, MD
MD
Radiation Oncology Physician
NPI: 1245339282IndividualAccepts Medicare
Specialties, Licenses & Credentials
Radiation Oncology PhysicianPrimary
Radiology — Radiation Oncology
Code: 2085R0001X
2012030860(MO)9600045(NC)
CMS Specialties
PrimaryRADIATION ONCOLOGY
Education
GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE
Class of 1994
Clinical Trials (2)
2
Linked Trials
0
Recruiting
1
With Results
Research & Publications (20)
Antidepressant emergent mood switch in major depressive disorder: onset, clinical correlates and impact on suicidality.
PMID 37351585·Int Clin Psychopharmacol·2023
8-other
Clinical correlates and prognostic implications of severe suicidal ideation in major depressive disorder.
PMID 36853754·Int Clin Psychopharmacol·2023
8-other
Clinical correlates and prognostic impact of binge-eating symptoms in major depressive disorder.
PMID 35815954·Int Clin Psychopharmacol·2022
3-trial
Persistence of suicidal ideation within acute phase treatment of major depressive disorder: analysis of clinical predictors.
PMID 35695646·Int Clin Psychopharmacol·2022
8-other
Obsessive-compulsive symptoms in major depressive disorder correlate with clinical severity and mixed features.
PMID 35191860·Int Clin Psychopharmacol·2022
8-other
Post-traumatic stress disorder and childhood emotional abuse are markers of subthreshold bipolarity and worse treatment outcome in major depressive disorder.
PMID 34686642·Int Clin Psychopharmacol·2022
8-other
Childhood maltreatment and impact on clinical features of major depression in adults.
PMID 32950785·Psychiatry Res·2020
8-other
Irritability and Its Clinical Utility in Major Depressive Disorder: Prediction of Individual-Level Acute-Phase Outcomes Using Early Changes in Irritability and Depression Severity.
PMID 30922100·Am J Psychiatry·2019
8-other
Studying treatment-effect heterogeneity in precision medicine through induced subgroups.
PMID 30794033·J Biopharm Stat·2019
8-other
The Concise Health Risk Tracking Self-Report (CHRT-SR) assessment of suicidality in depressed outpatients: A psychometric evaluation.
PMID 30370613·Depress Anxiety·2019
4-observational
Proteomics profiling reveals inflammatory biomarkers of antidepressant treatment response: Findings from the CO-MED trial.
PMID 28628884·J Psychiatr Res·2017
2-rct
Can C-reactive protein inform antidepressant medication selection in depressed outpatients? Findings from the CO-MED trial.
PMID 28187400·Psychoneuroendocrinology·2017
2-rct
Cross-trial prediction of treatment outcome in depression: a machine learning approach.
PMID 26803397·Lancet Psychiatry·2016
4-observational
Adherence to antidepressant combinations and monotherapy for major depressive disorder: a CO-MED report of measurement-based care.
PMID 24638046·J Psychiatr Pract·2014
4-observational
The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations.
PMID 22687487·J Clin Psychiatry·2012
4-observational
Correlates and outcomes of depressed out-patients with greater and fewer anxious symptoms: a CO-MED report.
PMID 22129562·Int J Neuropsychopharmacol·2012
2-rct
Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: an exploratory report from the Combining Medications to Enhance Depression Outcomes Study.
PMID 22075098·J Clin Psychiatry·2011
4-observational
Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study.
PMID 21536692·Am J Psychiatry·2011
4-observational
Normal tissue tolerance for high-grade gliomas: is it an issue?
PMID 19464634·Semin Radiat Oncol·2009
8-other
Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells.
PMID 16397244·Cancer Res·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 101 MANNING DR
CHAPEL HILL, NC 27599 - Phone
- (919) 966-8596
Quick Facts
- NPI
- 1245339282
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 32
- Clinical Trials
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile